Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2022

Feb 07, 2023

SELL
$4.35 - $6.77 $33,930 - $52,806
-7,800 Reduced 72.22%
3,000 $10,000
Q3 2022

Oct 25, 2022

BUY
$3.65 - $6.43 $14,965 - $26,363
4,100 Added 61.19%
10,800 $31,000
Q2 2022

Aug 04, 2022

SELL
$2.68 - $6.14 $9,112 - $20,876
-3,400 Reduced 33.66%
6,700 $37,000
Q1 2022

Apr 14, 2022

BUY
$5.05 - $7.53 $32,320 - $48,192
6,400 Added 172.97%
10,100 $29,000
Q1 2021

Apr 26, 2021

BUY
$12.83 - $42.25 $47,471 - $156,325
3,700 New
3,700 $10,000

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $1.09B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.